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Abstract Human dipeptidylpeptidase IV (hDPPIV)
is an enzyme that is in hydrolase class and has various
roles in different parts of human body. Its deficiency
may cause some disorders in the gastrointestinal,
neurologic, endocrinological and immunological sys-
tems of humans. In the present study, hDPPIV enzyme
was expressed on Spodoptera frugiperda (Sf9) cell
lines as a host cell, and the expression of hDPPIV was
obtained by a baculoviral expression system. The
enzyme production, optimum multiplicity of infec-
tion, optimum transfection time, infected and unin-
fected cell size and cell behavior during transfection
were also determined. For maximum hDPPIV (269
mU mL-1) enzyme, optimum multiplicity of infec-
tion (MOI) and time were 0.1 and 72 h, respectively.
The size of infected cells increased significantly
(P \ 0.001) after 24 h post infection. The results
indicated that Sf9 cell line was applicable to the large
scale for hDPPIV expression by using optimized
parameters (infection time and MOI) because of its
high productivity (4.03 mU m L-1 h-1).
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Introduction
Human dipeptidyl peptidase IV (hDPPIV, EC
3.4.14.5) is a multifunctional type II transmembrane
serine protease that catalyzes the release of N-terminal
dipeptides from proline sites by hydrolysis (Bergmann
and Bohuon 2002; Thoma et al. 2003). The enzyme is
also known as an important signaling molecule CD26
on T and B lymphocytes and it is expressed in a variety
of cell types, microbial (Demuth and Heins 1995;
Cunningham and O’Connor 1997; Pe´rez-Guzma´n
et al. 2004), insect cells and nearly all mammalian
tissues. hDPPIV regulates various physiological pro-
cesses including immune system, endocrine functions,
central nervous system, gastrointestinal system,
inflammation, rheumatoid arthritis and cell adhesion.
The enzyme removes dipeptides from N-terminus of
regulatory peptides such as chemokines, neuropep-
tides and peptide hormones (Reichelt et al. 1981;
Shattock et al. 1990; Urade et al. 2006; Iwaki-Egawa
et al. 1998; Mentlein 1999; Brudnak 2001; Brudnak
et al. 2002; Langford 2003; Lambeir et al. 2002;
Reichelt and Knivsberg 2003; Aertgeerts et al. 2004;
Reinhold et al. 2009).
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Recently, hDPPIV has been used as a dietary
supplement alone or in combination with other
nutritional enzymes by the patients who are suffering
from lack of hydrolysis enzyme. It has been commer-
cially produced by some Aspergillus strains (Tachi
et al. 1992; Doumas et al. 1998; Wilkinson and
Houston 2001; Jalving et al. 2005; Ota et al. 2005).
Recombinant protein production from baculovirus-
insect cell system has some advantages like very high
level of recombinant protein through post translational
processing and modification of higher eukaryotes.
However, large scale production of the enzyme from
insect cell is very limited because of the commercial
concerns like the cost of experimental tools and
productivity (Effio et al. 2003; Ikonomou et al. 2003;
Hitchman et al. 2009).
In the current study, the expression of hDPPIV was
performed by using baculovirus infected insect cell
line (Spodoptera frugiperda, Sf9). Monitoring the
effect of transfection reactions on the cell character-
istics is scarce in the literature. Therefore, the
efficiency of transfection, optimum multiplicity of
infection (MOI), optimum transfection time, cell
behavior and cell size were monitored to determine
optimal harvest time for large scale production of Sf9
cell line and expression of hDPPIV.
Determining the characteristics of transfected Sf9
cells might be useful to find out the point of peak
protein production and to predict the maximum
protein yield, thus stable and economical recombinant
protein expression can be achieved. These character-
istics may be differentiated according to cell line.
Therefore, there are no certain signals about the
transfection and/or infection effect on the insect cells.
This current study may be a resource for those
interested in a large scale production of recombinant
hDPPIV enzyme on Sf9 cell line.
Materials and methods
Cell line and baculovirus
The insect cell line was Spodoptera frugiperda, Sf9
(Invitrogen, USA) derived from the pupal ovarian
tissue of the fall army worm, and Autographa
californica nucleopolyhedrovirus was used as a
recombinant baculovirus. The transfer vector was
pFastBac1, competent Escherichia coli DH10Bac
cells, Sf 900 II SF medium, Cellfectin II and antibi-
otics were purchased from Invitrogen (Gibco BRL
USA); Bluo-gal, IPTG and protease inhibitor mixture
were from Sigma (USA).
Plasmid construction
The full-length cDNA of hDPPIV/CD26 was obtained
from pEBFP-N1-DPPIV (Madgeburg University, Ger-
many), and hDPPIV gene was amplified by PCR using
forward and reverse primers. The primers used are
shown below:Forward primer: 50-CGCGGATCCAT
GAAGACACCGTGGAAGGTT-30Reverse primer:
50-GCGACTAGTCTAAGGTAAAGAGAAACATT
G-30. PCR was performed for KOD plus protocol and
under following conditions: 1 lM Forward primer,
1 lM Reverse primer, 0.1 lg DNA template, 5 ll
dNTPs, 2 ll MgSO4, Milli-Q water to a final volume of
50 ll. Amplification was achieved upon 2 min at
94 C, 30 cycles of at 60 C, and an extension step, at
68 C, for 2.31 min. The PCR products were loaded to
agarose gel (0.8 %, w/v) for confirmation. The PCR
products containing the hDPPIV, were digested with
BamH1 and Spe1 restriction enzymes in order to insert
the DNA, in frame, into the pFastBacl transfer vector
(Gibco BRL, USA) of the Baculovirus Expression
System (Invitrogen, USA). The recombinant plasmids
were used to transform competent E.coli DH10B and
then DH10Bac (containing the wild-type baculovirus
genome in bacmid form) to generate the correspond-
ing recombinant bacmids upon transposition. Cloning
steps were monitored by using sequence analysis and
controlled by Genetyx-Win Program.
Transformation of baculoviral hDPPIV to E.coli
DH10Bac
One vial of DH10Bac competent cells (100 ll) were
thawed on ice for each transformation. 1 ng hCD26/
pFastBac1 plasmid DNA were added to the cells and
mixed gently. The cells were incubated on ice for
30 min. Heat shock was applied to the cells for 45 s at
42 C without shaking and immediately transferred
the tubes to ice and chilled for 2 min. SOC (Super
Optimal broth with Catabolite Repression) medium
was added 900 ll at room temperature and shake at
37 C at 225 rpm for 4 h. Serial dilutions of the cells
(10-1, 10-2, 10-3) was prepared with SOC medium.
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Each dilution was plated on LB (Luria Broth) agar that
contained 50 lg mL-1 kanamycin, 7 lg mL-1 gen-
tamicin, 10 lg mL-1 tetracycline, 100 lg mL-1
Bluo-gal and 40 lg mL-1 IPTG. The plates were
incubated for 48 h at 37 C. White colonies, which
include recombinant bacmid E. coli clones, were
picked by blue/white-screening (Invitrogen).
Production of recombinant baculovirus
After transformation of E. coli DH10Bac cells,
Spodoptera frugiperda cells were cultured at 27 C
in Sf900-II SFM medium, supplemented with genta-
micin (50 lg mL-1). For transfection, 9 9 105 cells
were plated in 6 well tissue culture dishes and
incubated for 1 h in 2 mL Sf900-II SFM without
antibiotics to allow adhesion of the cells to surface.
Recombinant bacmid DNA had been preincubated for
45 min at room temperature with Cellfectin II (6 ll).
Cells were incubated with the liposome–DNA com-
plex for 5 h at 27 C. The transfection medium was
removed and 2 mL of Sf900-II SFM medium, con-
taining antibiotics was added. The DNA was trans-
fected into Sf9 cells. Transfected cells were incubated
at 27 C for 144 h allowing baculovirus production.
The recombinant virus was amplified twice to
obtain virus stocks of the highest titer and harvested.
Classical plaque assay was applied for virus titration
(Summers and Smith 1987).
Optimization of human DPPIV protein expression
and transfection
Sf9 cells in 6 well plates (Sf-900 II SF medium, 10 %
v/v heat-inactivated FBS and gentamicin (w/v,
50 lg mL-1) were infected by recombinant virus
with MOI of 0.1, 0.25, 0.5, 0.75, 1 and 10 plaque-
forming units per cell. Cells were harvested 24, 48, 72,
96, 120 and 144 h post transfection and centrifuged for
5 min at 100 g. The cells were washed three times
with phosphate-buffered saline (PBS) and then resus-
pended on ice in 300 ll of sonication buffer (20 mM
Tris–HCl pH 8.0, 300 mM NaCl, 10 % (w/v) glycerol,
IPEGAL CA-630) for 9 9 105 cells mL-1. After
sonication three times at 20 s pulses with a Bandelin
model sonicator at 45 % power, samples were centri-
fuged at 4 C for 10 min at 12,000g. DPPIV activities
were measured to determine optimum MOI with the
maximum hDPPIV expression.
Determination of virus replication and cytopathic
effects
Viral transfection may lead to cytopathic effects and
structural changes in the host cell. The effects of
transfection with MOI 0.1 on the cells were measured
by using mitochondrial tetrazolium test [MTT, 3-(4,5-
dimetiltiazol-2-il)-2,5- difenil-tetrazolium bromid
assay] in every 6 h for 72 h post transfection (Celis
et al. 2005). The viability of uninfected and infected
cells was calculated, and the results were compared
with the Student’s t test (Statistical Package for the
Social Science for Windows, SPSS 17.0).
Measuring of Sf9 cell size during transfection
Transfection may cause changes in cell properties by
the introduction of DNA, and the most distinctive
change is the size of infected cells. After transfection
with the MOI 0.1, 100 ll samples were placed into
cover glass, and the cell sizes were measured under an
inverse phase microscope (Olympus, Japan) for 100
cells from 10 different areas. The arithmetic averages
of the cell sizes were calculated and the results were
compared with the Student’s t test.
Monitoring hDPPIV expression and baculovirus
replication with immunofluorescence method
The immunofluorescence method was used to detect
the location and relative abundance of baculovirus and
hDPPIV enzyme. CD26 rabbit polyclonal antibody
(CD 26-H270:sc-9153; Santa Cruz, USA) and gp64
monoclonal antibody (gp 64-AcV5-ab91214; Abcam,
UK) were used as primer antibodies, also goat
antirabbit (594; Invitrogen, UK) and goat antimouse
(488; Invitrogen, UK) IgG were seconder antibodies.
Determination of protein concentration, enzymatic
activity and western blot
After transfection, cells were harvested at 24 h
intervals for Western blot and enzymatic analysis.
Enzymatic activity was determined with Gly-Pro-p-
nitroanilide as a substrate as described previously
(Pe´rez-Guzma´n et al. 2004). Western blot samples
(1.5 mL) were centrifuged at 16,000g for 2.5 min.
After removing the supernatant, the cell pellets were
stored at -25 C. The protein concentration was
Cytotechnology (2014) 66:159–168 161
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determined with the BCA Protein Assay Reagent Kit
(Pierce, USA).
Results
Optimization of hDPPIV protein expression
and transfection parameters
Production of recombinant baculovirus
The plasmid construct was successfully transfected
into E.coli DH10B and then DH10Bac, which resulted
in the generation of the bacmid DNA. A detail of the
cloning strategy and nucleotid sequence of hDPPIV is
described in Fig. 1. Sf9 cells were transfected with this
bacmid DNA by using cationic lipid agent for protein
expression. Transfection was monitored daily by
measuring the enzyme activity for post transfection.
Expression of hDPPIV enzyme was similar in unin-
fected and infected Sf9 cells for 24 h, but it increased
after 48 h post infection, and finally the maximum
enzyme activity was determined for 96 h post infec-
tion. The expression of this enzyme decreased slightly
after 120 h post infection (Fig. 2). Changes in cell
shape, cell size and density of the cells are indicated in
Fig. 3. The cells became bigger and more rounded
while the number of cells decreased, and cells lost
adherence ability to the culture plate obviously after
72 h post transfection. These typical changes in the
morphological properties of cells at post transfection
were reported in the literature (Radner et al. 2012).
The maximum enzyme activity was obtained at
96 h post transfection. However, when the transfec-
tion productivity (enzyme activity per hours) consider,
it can clearly be seen that 72 h post transfection
(4.03 mU mL-1 h-1) could be better than 96 h
(3.62 mU mL-1 h-1) for optimum transfection.
Transfected Sf9 cells were harvested and loaded
into Western blot gel. The Western blot results implied
that the expression of recombinant hDPPIV on
infected Sf9 cells was increased at 72 h post transfec-
tion, while expression of hDPPIV had insignificant
changes in uninfected cells (Fig. 4). The molecular
mass of hDPPIV was about 70 kDa according to the
marker on the gel. This molecular mass had already
been predicted from the amino acid sequence of
hDPPIV (2,300 bp) (Tanaka et al. 1992; Thoma et al.
2003). The result was in consistence with previous
studies (Chang et al. 1999; Slack et al. 2001; Slack and
Lawrence 2002; Ogay et al. 2006).
The enzyme activities of the samples, which were
loaded to the Western blot, for uninfected cells were
2.62 ± 0.1 mU mL-1 at 24 h, 7.88 ± 0.24 mU mL-1
at 48 h and 12.79 ± 2.01 mU mL-1 at 72 h, while
the activities for infected cells at 24, 48 and 72 h
increased to 2.86 ± 0.14, 8.36 ± 0.34 and 291.91 ±
5.73 mU mL-1, respectively.
Next to the transfection time for standard recombi-
nant enzyme production, MOI was another important
parameter. First, a logarithmic pattern was formed for
MOI as 0.1, 1 and 10 for 24, 48, 72, 96, 120 and 144 h
post transfection. hDPPIV expression levels were
monitored by measuring the enzyme activity. The
enzyme activity time course is shown in Fig. 5.
As shown in Fig. 5, the expression of hDPPIV with
MOI 0.1 was similar to MOI 1 and three times higher
than MOI 10. The results indicated that the range of
MOI 0.1–1 should be studied further for the maximum
hDPPIV expression. Therefore, different ratios of
MOI were performed as 0.1, 0.25, 0.5, 0.75 and 1 in the
range for 24, 48, 72, 96, 120 and 144 h post
transfection, respectively (Fig. 6).
The amount of expressed hDPPIV from infected
Sf9 cells was found similar from MOI 0.1 to 1.
Baculovirus replication and cytopathic effects
The transfected Sf9 cells showed typical cytopathic
effects such as ceasing of cell growth and decreasing
of the infected cell viability. The viability of infected
and uninfected cells is given in Table 1. There was a
significant difference between the number of viable
uninfected and infected cells (P \ 0.001). Moreover,
irregular cell shapes, increasing cell size and lost
attachment were observed under inverse phase micro-
scope (Olympus, Japan). At the end of the 30 h post
infection, 60 % of adherent cells lost attachment
capability to the culture surface. Finally, at 66 h post
transfection the 80–90 % of the cells were detached
and formed clusters.
The effect of transfection on Sf9 cell morphology
The most distinctive effect of transfection on Sf9 cell
morphology was the cell size. As given in Fig. 7, the
size of uninfected cells was 18.0 ± 0.67 lm. Signif-
icant differences were found between uninfected and
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infected cell sizes after 24 h post infection
(P \ 0.001). The infected cells (MOI 0.1) were
monitored by using immunofluorescence method for
72 h post infection (Fig. 8). The immunofluoresence
images revealed that the percentage of baculovirus
increased gradually after 24 h post infection, and
hDPPIV was expressed from the transfected Sf9 cells
after 48 h post infection.
Correlation between the replication of baculovirus
and the expression of hDPPIV were detected by using
fluorescence intensity of infected cells and uninfected
cells. By the way, it was demonstrated that although
there was about 20 % increase in baculovirus infection,
hDPPIV expression increased only 3 % after 24 h post
infection. Expression of the hDPPIV from infected Sf9
cells rose gradually until 72 h post transfection before
increasing slightly at 96 h post transfection.
The results indicated that the transfection efficiency,
that is, percentage of transfected Sf9 cells in the
Fig. 1 Shematic of the cloning strategies and nucleotid
sequence of hDPPIV. a The hDPPIV gene was obtained from
pEBFP-N1-DPPIV inserted into thepFastBac1 cloning system,
and constructed plasmid was transformed E.coli DH10B. b PCR
screening of the positive E.coli DH10B colonies containing the
pFastBac1hDPPIV plasmid. c nucleotid sequence of hDPPIV
(ncbi. NM-001935 mRNA linear homo sapiens dipeptidyl
peptidase IV, CD26)
Fig. 2 Comparison of DPPIV expression with bacmid DNA by
using cationic lipid agent (Cellfectin II)
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population, was 81 %. Moreover, the ratio of the
number of infected cells (MOI = 0.1), which expressed
hDPPIV, to the total infected cells was 80 % (Fig. 9).
Discussion
Recently, baculovirus expression system and Sf9 cell
line have widely used for recombinant protein
production. The hDPPIV gene was successfully
Fig. 3 Time dependent morphological differentiations of insect cells after transfection
Fig. 4 Western blot analysis of DPPIV expression from
uninfected and infected cells
Fig. 5 Transfection of Sf9 cells with MOI 0.1, 1 and 10
Fig. 6 Transfection of Sf9 cells with MOI 0.1, 0.25, 0.5, 0.75
and 1
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expressed in the baculovirus-insect cell system in a
related study (Dobers et al. 2002). Examined param-
eters, MOI and infection time, were expanded to
determine optimum MOI value (0.1, 0.25, 0.5, 0.75,
1 and 10) and harvest time (0, 24, 72, 96, 120 and
144 h) in this study.
The entire process was monitored to observe
the effects of this approach. In addition to
hDPPIV activity and MOI against time, produc-
tivity of hDPPIV, and yield of the enzyme
determination of the change in the cell size were
also carried out. These parameters have been
considered as potentially useful items for moni-
toring infected cell cultures to determine the
maximum protein production and to calculate the
maximum productivity.
The most critical parameter for maximizing the
production is to find an optimal harvest time for
transfection of the cells. Therefore, productivity of
hDPPIV enzyme had been used to determine the time
of maximum protein production (enzyme activity),
and optimal harvest time hereby. As mentioned above,
since productivity of hDPPIV from infected Sf9 at
72 h was 1.11 fold higher than at 96 h. Therefore, post
infection of 72 h was performed as an optimum
harvest time (Fig. 2). Related manuscript have been
Table 1 Measurement of the viability of infected (MOI 0.1)
and uninfected Sf 9 cells by MTT assay
Time (hour) Number of the viable cells (cell.104.mL-1)
Uninfected
Sf9 cells
Infected
Sf9 cells
0 1 1
6 2.21 2.1
12 2.89 1.92
18 3.16 1.81
24 5.13 3.01
30 5.19 3.61
36 5.32 2.5
42 7.11 2.71
48 9.25 2.89
54 10.40 3.64
60 11.70 3.43
66 12.40 3.30
72 14.70 2.89
P \ 0.001
Fig. 7 Effect of transfection on Sf9 cell size
Fig. 8 Immunofluorescence images of baculovirus infected Sf9
cells. DAPI (column 1), gp64 (column 2), CD 26 (column 3) for
uninfected cells (line 1), 24 h (line 2), 48 h (line 3) and 72 h post
infection (line 4)
Fig. 9 Correlation between uninfected Sf9 cells, baculovirus
infected Sf9 cells and expression of DPPIV (from infected Sf9
cells) by using immunofluorescence images
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supported the data (Nishikawa et al. 2003; Sandhu
et al. 2007).
Monitoring methods may indicate some correla-
tions between cell density, enzyme activity or cell size
and infection rate. The data represented that density of
the infected cells was similar to the uninfected cells at
0 h. However, the infected cell density decreased
gradually until 144 h (Fig. 3). It is thought that density
of the infected cell may be related to recombinant
baculovirus replication in the cells or the infected cells
may change their metabolism in order that expressing
of hDPPIV instead of their growth. Hence, the results
indicate that there has been an opposite correlation
between cell density and infection, namely protein
production in infected cells. Whereas Nishikawa et al.
(2003) have supported the data, Sander and Harrysson
(2007) reported no strong connection between the cell
density and infection.
Although a similar pattern was found for infected
Sf9 cell line (with MOI = 0.1–1) in Fig. 6, the yields
of hDPPIV enzyme per MOI were measured as 2.69
and 0.3 Ucell.pfu-1 mL-1 for MOI = 0.1 and 1,
respectively. Therefore, MOI = 0.1 value was per-
formed as optimum MOI for expression of hDPPIV
from Sf9 cells. As it is well known, using low MOI is
preferable for industrial production because of the low
passage effects.
After infection with MOI = 0.1, infected cell
viability was checked by MTT assay and any sharp
decrease was not observed in viability of infected
cells. Therefore, it was thought that baculovirus could
not be a lytic virus, but could be a budded virus. The
baculovirus species is the most frequently used for
baculovirus studies. Brondyk (2009) remarked it as a
non-lytic virus.
The average diameter of the cells in the uninfected
cultures was 18.0 ± 0.67 lm at the beginning of
infection. The average size of uninfected Sf9 cells was
reported by Gotoh et al. (2008) as 18.5 ± 1.5 lm,
which is in correlation with the current study.
In the current study; Sf9 cells infected with low
MOI (0.1) swelled rapidly and reached to a point at
average 23 lm diameter at 72 h likewise the study by
Gotoh et al. (2008). The average diameters were
similar at the beginning of infection for uninfected and
infected cells, but the diameter of infected cells
increased by 42 % at 72 h post infection (Fig. 7).
Sander and Harrysson (2007) reported the increased
diameter of infected cell as 28 % with MOI = 0.5 at
the same time. It is clearly understood that the cell size
of Sf9 could be considered as one of the infection
signs.
Increased cell diameter leads to lack of membrane
resistant and becomes more fragile against hydrody-
namic forces like shear stress. Therefore, it is impor-
tant to measure the uninfected and infected cell
diameters, and calculate possible shear stress as
preliminary calculations before large scale production.
The immunofluorescence images supported the
findings from the cell diameter and cell density
experiments, and also showed baculovirus infected
Sf9 cells and expressed hDPPIV. In this study
proliferation of transfected Sf9 cell ceased, and cell
size increased after 24 h post infection. These findings
indicate that viral replication gained acceleration after
24 h post infection, and this situation cause increasing
in the number of infected Sf9 cells, which has been
also supported by Luckow (1991).
A success in the expression studies depends on the
efficiency of infection. Radner et al. (2012) found
infection efficiency approximately 20–30 % of Sf9
and Sf21 cells at 72 h, while another related study
gave the infection efficiency as 40–60 % (Pham et al.
2003). In the present study, the highest transfection
efficiency of recombinant hDPPIV was achieved by
80 % transfected Sf9 at 72 h. High infection efficiency
and the short incubation period have offered fast and
high yield recombinant protein production by large
scale infection of Sf9 cells.
In summary, the findings about optimum harvest
time, productivity, infection efficiency, also some
negative or positive correlations between cell density,
hDPPIV activity and cell size have been manifested.
The phenomenons might be a guide for baculoviral
hDPPIV producers from Sf9 cells.
The results of research that are described in this
report will be performed in the following study that is
based on scaling up hDPPIV expression from infected
Sf9 cell line.
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